Gene · 7372
Papers1,811
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,811
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Association of the expression of 5-FU biomarkers with aging and prognosis in elderly patients with lung cancer treated with S-1 adjuvant chemotherapy: Follow-up results of the Setouchi Lung Cancer Group Study 1201. | Mol Clin Oncol | 2025 | 40692744 | PubTator, text mining | PubMed |
| Identifying prognostic targets in metastatic prostate cancer beyond AR. | FEBS Open Bio | 2025 | 40405591 | PubTator, text mining | PubMed |
| Regulation of pyrimidine biosynthesis in the biocontrol bacterium Pseudomonas aureofaciens. | Folia Microbiol (Praha) | 2025 | 40159589 | PubTator, text mining | PubMed |
| Identification of target genes co-regulated by four key histone modifications of five key regions in hepatocellular carcinoma. | Methods | 2024 | 39349287 | PubTator, text mining | PubMed |
| Structural and systems characterization of phosphorylation on metabolic enzymes identifies sex-specific metabolic reprogramming in obesity. | bioRxiv | 2024 | 39257804 | PubTator, text mining | PubMed |
| Resistance to 5-fluorouracil: The molecular mechanisms of development in colon cancer cells. | Eur J Pharmacol | 2024 | 39241942 | PubTator, text mining | PubMed |
| Employing a synergistic bioinformatics and machine learning framework to elucidate biomarkers associating asthma with pyrimidine metabolism genes. | Respir Res | 2024 | 39217320 | PubTator, text mining | PubMed |
| Bioinformatics analysis and experimental verification of the cancer-promoting effect of DHODH in clear cell renal cell carcinoma. | Sci Rep | 2024 | 38796629 | PubTator, text mining | PubMed |
| p53 activation enhances the sensitivity of non-small cell lung cancer to the combination of SH003 and docetaxel by inhibiting de novo pyrimidine synthesis. | Cancer Cell Int | 2024 | 38704578 | PubTator, text mining | PubMed |
| GPX3-Mediated Oxidative Stress Affects Pyrimidine Metabolism Levels in Stomach Adenocarcinoma via the AMPK/mTOR Pathway. | Int J Clin Pract | 2024 | 38322113 | PubTator, text mining | PubMed |
| Genetic causal association between frozen shoulder and carpal tunnel syndrome: a two-sample mendelian randomization. | BMC Musculoskelet Disord | 2024 | 38216946 | PubTator, text mining | PubMed |
| A new physiological medium uncovers biochemical and cellular alterations in Lesch-Nyhan disease fibroblasts. | Mol Med | 2024 | 38172668 | PubTator, text mining | PubMed |
| Drug repurposing screen identifies vidofludimus calcium and pyrazofurin as novel chemical entities for the development of hepatitis E interventions. | Virol Sin | 2024 | 37984761 | PubTator, text mining | PubMed |
| Deciphering treatment resistance in metastatic colorectal cancer: roles of drug transports, EGFR mutations, and HGF/c-MET signaling. | Front Pharmacol | 2023 | 38269272 | PubTator, text mining | PubMed |
| Metabolic Enzymes in Viral Infection and Host Innate Immunity. | Viruses | 2023 | 38257735 | PubTator, text mining | PubMed |
| Comparing the Benefits and Drawbacks of Stem Cell Therapy Based on the Cell Origin or Manipulation Process: Addressing Immunogenicity. | Immune Netw | 2023 | 38188600 | PubTator, text mining | PubMed |
| An Overview on Lipid Droplets Accumulation as Novel Target for Acute Myeloid Leukemia Therapy. | Biomedicines | 2023 | 38137407 | PubTator, text mining | PubMed |
| Inhibition of DHODH Enhances Replication-Associated Genomic Instability and Promotes Sensitivity in Endometrial Cancer. | Cancers (Basel) | 2023 | 38136273 | PubTator, text mining | PubMed |
| Vidofludimus inhibits porcine reproductive and respiratory syndrome virus infection by targeting dihydroorotate dehydrogenase. | Vet Res | 2023 | 38124181 | PubTator, text mining | PubMed |
| Gene-metabolite annotation with shortest reactional distance enhances metabolite genome-wide association studies results. | iScience | 2023 | 38077122 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7372/papers?page=2